Outcomes from a pilot online Acceptance and Commitment Therapy program for dementia family caregivers.
Elizabeth B Fauth, Josh R Novak, Michael E Levin
https://pubmed.ncbi.nlm.nih.gov/34233133/Actively Recruiting
Led by Utah State University · Updated on 2026-09-28
120
Participants Needed
1
Research Sites
21 weeks
Total Duration
Researchers are evaluating an online self-guided Acceptance and Commitment Therapy ACT program designed to support family caregivers of people with dementia who experience psychological distress such as depression, anxiety, and stress. This study aims to explore whether the intervention improves caregivers mental health by increasing psychological flexibility, which helps individuals better manage negative thoughts and feelings. The trial will also investigate how adherence to the program affects these outcomes. Participants will be randomly assigned to either an immediate treatment group or a waitlist control group. The treatment involves working through six online sessions at their own pace, each session taking about 20 to 40 minutes, ideally completed weekly over six weeks. The waitlist group will receive the intervention 12 weeks after baseline assessment. This design allows all participants to eventually access the program while enabling comparisons between groups. Throughout the study, participants will complete assessments at baseline, six weeks posttest, and twelve weeks follow-up, including the Depression, Anxiety, and Stress Scale DASS-21 to measure psychological distress. Additional measures include caregiver burden and positive aspects of caregiving. Researchers will monitor adherence by tracking session completion and use advanced statistical analyses to understand how changes in psychological flexibility relate to changes in distress. The study will last approximately 12 weeks per participant.
CONDITIONS
ACT for Dementia Caregivers: Evaluating Psychological Flexibility as the Mechanism to Improve Psychological Distress
E
Elizabeth B. Fauth, PhD
H
Heather H Kelley, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Utah State University
Lead Sponsor
National Institute on Aging (NIA)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | ACT for Caregivers (digital self‑guided ACT) | Waitlist Control | Typical Internet‑based Psychosocial Support |
|---|---|---|---|
| What it is | A self‑guided digital Acceptance and Commitment Therapy (ACT) program for family caregivers, delivered online over six sessions to build psychological flexibility. | A waitlist control condition where participants do not receive the intervention during their control period. | Internet‑based psychosocial or digital support interventions are often used to help dementia caregivers manage burden, depression, or distress. |
| Role in trial | Investigational intervention evaluated for its effect on caregiver psychological distress. | Serves as the comparator arm in the crossover design with no intervention during that period. | Represents existing non‑trial caregiver support options offered outside research. |
| Primary use | Designed to reduce psychological distress (depression, anxiety, stress) in dementia caregivers by increasing psychological flexibility. | No active intervention; used to compare outcomes when caregivers receive ACT versus a delay. | Used to support caregiver well‑being through mood, burden, and quality‑of‑life improvement. |
| How it is delivered | Delivered online with six asynchronous sessions encouraged at one per week, each lasting about 20‑40 minutes, completed at home. | Participants wait during control period without receiving the intervention. | Typically delivered via websites or apps offering psychoeducational or self‑help modules with variable formats and durations. |
| Evidence status | Pilot data suggest feasibility and potential improvement in distress and psychological flexibility; efficacy to be tested in this randomized crossover trial. | Efficacy depends on comparison within the trial; by design, no therapeutic benefit during waitlist period. | Meta‑analytic evidence shows digital psychological interventions can reduce caregiver burden, depression, and improve quality of life. |
| Important risks | Potential digital intervention risks (e.g., low adherence) identified in feasibility studies, but no serious adverse effects reported. | No risks from intervention, but participants may experience continued distress while waiting. | Digital support interventions may face adherence challenges and variable engagement; serious risks are not commonly reported. |
| Important limitations | Self‑guided format may result in variable adherence; pilot evidence is limited in scope, and generalizability awaits full trial results. | Waitlist control does not reflect active support and does not allow comparison with existing interventions. | Interventions vary widely in format and content; quality and efficacy are heterogeneous across studies. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 baseline survey
Duration - Up to 12 weeks
Participants in the treatment group complete six online self-guided ACT sessions at their own pace, encouraged to finish one per week over six weeks. The waitlist group receives the program 12 weeks after baseline.
Assessments at baseline, 6 weeks, and 12 weeks
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Elizabeth B Fauth, Josh R Novak, Michael E Levin
https://pubmed.ncbi.nlm.nih.gov/34233133/Utah State University
Lead Sponsor
National Institute on Aging (NIA)
Collaborating Sponsor